NASDAQ:ECOR

electroCore Stock Forecast, Price & News

$3.05

+0.31 (+11.31 %)

(As of 01/26/2021 12:00 AM ET)

Add

Compare

Today's Range

$2.86

Now: $3.05▼

$3.29

50-Day Range

$1.44

MA: $1.79▼

$2.74

52-Week Range

$0.32

Now: $3.05▼

$3.30

Volume6.28 million shs

Average Volume3.10 million shs

Market Capitalization$138.63 million

P/E RatioN/A

Dividend YieldN/A

Beta1.62

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.

Overall MarketRank^™

1.03 out of 5 stars

Medical Sector

957th out of 1,925 stocks

Electromedical Equipment Industry

24th out of 61 stocks

2.4 Analyst's Opinion

Consensus Rating
electroCore has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.42, electroCore has a forecasted upside of 12.0% from its current price of $3.05.
Amount of Analyst Coverage
electroCore has only been the subject of 1 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
electroCore has received 148 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
electroCore has received 198 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
electroCore has received 57.23% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about electroCore and other stocks. Vote “Outperform” if you believe ECOR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ECOR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
electroCore does not currently pay a dividend.
Dividend Growth
electroCore does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, electroCore insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 24.90% of the stock of electroCore is held by insiders.
Percentage Held by Institutions
Only 5.45% of the stock of electroCore is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for electroCore are expected to grow in the coming year, from ($0.58) to ($0.38) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of electroCore is -3.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of electroCore is -3.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
electroCore has a P/B Ratio of 3.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:ECOR

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.electrocore.com

Phone973-290-0097

Employees51

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.05

Current Ratio4.92

Quick Ratio4.78

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.39 million

Price / Sales58.01

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.84 per share

Price / Book3.63

Profitability

EPS (Most Recent Fiscal Year)($1.54)

Net Income$-45,150,000.00

Net Margins-792.01%

Return on Equity-109.15%

Return on Assets-79.64%

Miscellaneous

Outstanding Shares45,454,000

Market Cap$138.63 million

Next Earnings Date3/22/2021 (Estimated)

OptionableNot Optionable

$3.05

+0.31 (+11.31 %)

(As of 01/26/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ECOR News and Ratings via Email

Sign-up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

electroCore (NASDAQ:ECOR) Frequently Asked Questions

How has electroCore's stock price been impacted by Coronavirus (COVID-19)?

electroCore's stock was trading at $0.5874 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ECOR shares have increased by 419.2% and is now trading at $3.05.
View which stocks have been most impacted by COVID-19.

Is electroCore a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" electroCore stock.
View analyst ratings for electroCore or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than electroCore?

Wall Street analysts have given electroCore a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but electroCore wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is electroCore's next earnings date?

electroCore is scheduled to release its next quarterly earnings announcement on Monday, March 22nd 2021.
View our earnings forecast for electroCore.

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.10) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.12) by $0.02. The firm earned $1.08 million during the quarter, compared to the consensus estimate of $1 million. electroCore had a negative net margin of 792.01% and a negative trailing twelve-month return on equity of 109.15%.
View electroCore's earnings history.

What guidance has electroCore issued on next quarter's earnings?

electroCore issued an update on its FY 2020 IntraDay earnings guidance on Monday, January, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.5-3.5 million, compared to the consensus revenue estimate of $3.41 million.

What price target have analysts set for ECOR?

6 equities research analysts have issued 12 month price targets for electroCore's stock. Their forecasts range from $2.00 to $5.00. On average, they expect electroCore's share price to reach $3.42 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price.
View analysts' price targets for electroCore or view Wall Street analyst' top-rated stocks.

Are investors shorting electroCore?

electroCore saw a drop in short interest in December. As of December 31st, there was short interest totaling 527,800 shares, a drop of 17.3% from the December 15th total of 638,400 shares. Based on an average trading volume of 539,800 shares, the short-interest ratio is presently 1.0 days.
View electroCore's Short Interest.

Who are some of electroCore's key competitors?

Some companies that are related to electroCore include Cutera (CUTR), Stereotaxis (STXS), Edap Tms (EDAP), Soleno Therapeutics (SLNO), BioSig Technologies (BSGM), FONAR (FONR), ENDRA Life Sciences (NDRA), Electromed (ELMD), IRIDEX (IRIX), Second Sight Medical Products (EYES), Fc Global Realty (FCRE), ReShape Lifesciences (RSLS), CHF Solutions (CHFS), Helius Medical Technologies (HSDT) and Precision Optics (PEYE).
View all of ECOR's competitors.

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

Who are electroCore's key executives?

electroCore's management team includes the following people:

Mr. Daniel S. Goldberger, CEO & Director (Age 62, Pay $187.5k)
Mr. Joseph P. Errico, Co-Founder, Principal Investor & Director (Age 52, Pay $776.28k)
Mr. Brian M. Posner, CFO & Corp. Sec. (Age 59, Pay $380.54k)
Dr. Peter S. Staats, Chief Medical Officer (Age 57, Pay $238.41k)
Mr. Michael Romaniw, Exec. VP of Systems & Operations (Age 64)
Ms. Jackie Dorsky, Director of Marketing
Ms. Carrie Kochek, Sr. Director of HR
Mr. Eric J. Liebler, Sr. VP of Neurology (Age 57)

When did electroCore IPO?

(ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. Evercore ISI and JMP Securities served as the underwriters for the IPO and BTIG was co-manager.

What is electroCore's stock symbol?

electroCore trades on the NASDAQ under the ticker symbol "ECOR."

How do I buy shares of electroCore?

Shares of ECOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is electroCore's stock price today?

One share of ECOR stock can currently be purchased for approximately $3.05.

How big of a company is electroCore?

electroCore has a market capitalization of $138.63 million and generates $2.39 million in revenue each year. The company earns $-45,150,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis. electroCore employs 51 workers across the globe.

What is electroCore's official website?

The official website for electroCore is www.electrocore.com.

How can I contact electroCore?

electroCore's mailing address is 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920. The company can be reached via phone at 973-290-0097 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here